127 related articles for article (PubMed ID: 6517543)
1. Pharmacokinetics and metabolism of rosaramicin in humans.
Lin CC; Chung M; Gural R; Schuessler D; Kim HK; Radwanski E; Marco A; DiGiore C; Symchowicz S
Antimicrob Agents Chemother; 1984 Oct; 26(4):522-6. PubMed ID: 6517543
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of [14C]rosaramicin in dogs.
Lin CC; Kim HK; Marco A; Radwanski E; Symchowicz S
Antimicrob Agents Chemother; 1986 May; 29(5):753-6. PubMed ID: 3729339
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
[TBL] [Abstract][Full Text] [Related]
4. The excretion of rosaramicin in breast milk.
Stoehr GP; Juhl RP; Veals J; Symchowicz S; Gural R; Lin C; McDonald RH
J Clin Pharmacol; 1985 Mar; 25(2):89-94. PubMed ID: 3988965
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of an intravenously administered penem (Sch 34343) in humans.
Lin CC; Lim J; Radwanski E; Kim HK; Marco A; Lapiguera A; DiGiore C; Symchowicz S
Antimicrob Agents Chemother; 1987 Jan; 31(1):84-7. PubMed ID: 3566242
[TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Blight AR; Henney HR
Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
[TBL] [Abstract][Full Text] [Related]
8. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects.
Holmberg AA; Weidolf L; Necander S; Bold P; Sidhu S; Pelay-Gimeno M; de Ligt RAF; Verheij ER; Jauhiainen A; Psallidas I; Wählby Hamrén U; Prothon S
Drug Metab Dispos; 2022 Feb; 50(2):150-157. PubMed ID: 34853068
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of a metabolite of rosaramicin in human urine.
Lin C; Puar MS; Schuessler D; Prananik BN; Symchowicz S
Drug Metab Dispos; 1984; 12(1):51-6. PubMed ID: 6141912
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
12. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.
Muirhead GJ; Rance DJ; Walker DK; Wastall P
Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):13S-20S. PubMed ID: 11879255
[TBL] [Abstract][Full Text] [Related]
13. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, absorption, metabolism, and excretion of [
Prakash C; Fan B; Altaf S; Agresta S; Liu H; Yang H
Cancer Chemother Pharmacol; 2019 May; 83(5):837-848. PubMed ID: 30758648
[TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
Nave R; Bethke TD; van Marle SP; Zech K
Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of orally administered tizanidine in healthy volunteers.
Tse FL; Jaffe JM; Bhuta S
Fundam Clin Pharmacol; 1987; 1(6):479-88. PubMed ID: 3447935
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
Barbhaiya RH; Dandekar KA; Greene DS
Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the metabolic fate of 14C-rokitamycin. Absorption, distribution, metabolism and excretion in infant rats].
Sakai A; Iwasaki M; Suzuki T; Morishita M; Muranishi S
Jpn J Antibiot; 1988 Jul; 41(7):797-808. PubMed ID: 3172452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]